BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang DP, Liu KL, Li XY, Lu GQ, Xue WH, Qian XH, Mohamed O K, Meng FH. Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1,2,3-triazole scaffold. Eur J Med Chem 2021;211:113083. [PMID: 33340911 DOI: 10.1016/j.ejmech.2020.113083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Alanazi MM, Elkady H, Alsaif NA, Obaidullah AJ, Alanazi WA, Al-hossaini AM, Alharbi MA, Eissa IH, Dahab MA. Discovery of new quinoxaline-based derivatives as anticancer agents and potent VEGFR-2 inhibitors: Design, synthesis, and in silico study. Journal of Molecular Structure 2022;1253:132220. [DOI: 10.1016/j.molstruc.2021.132220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Yao Y, Huang T, Wang Y, Wang L, Feng S, Cheng W, Yang L, Duan Y. Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors. J Enzyme Inhib Med Chem 2022;37:652-65. [PMID: 35109719 DOI: 10.1080/14756366.2022.2032688] [Reference Citation Analysis]
3 Alam MM. 1,2,3-Triazole hybrids as anticancer agents: A review. Arch Pharm (Weinheim) 2022;355:e2100158. [PMID: 34559414 DOI: 10.1002/ardp.202100158] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nafie MS, Boraei AT. Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer. Bioorganic Chemistry 2022;122:105708. [DOI: 10.1016/j.bioorg.2022.105708] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hassan RA, Emam SH, Hwang D, Kim GD, Hassanin SO, Khalil MG, Abdou AM, Sonousi A. Design, synthesis and evaluation of anticancer activity of new pyrazoline derivatives by down-regulation of VEGF: Molecular docking and apoptosis inducing activity. Bioorg Chem 2022;118:105487. [PMID: 34798455 DOI: 10.1016/j.bioorg.2021.105487] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
6 Dhokne P, Sakla AP, Shankaraiah N. Structural insights of oxindole based kinase inhibitors as anticancer agents: Recent advances. Eur J Med Chem 2021;216:113334. [PMID: 33721669 DOI: 10.1016/j.ejmech.2021.113334] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Wang H, Li Y, Wang X, Li Y, Cui J, Jin DQ, Tuerhong M, Abudukeremu M, Xu J, Guo Y. Preparation and structural properties of selenium modified heteropolysaccharide from the fruits of Akebia quinata and in vitro and in vivo antitumor activity. Carbohydr Polym 2022;278:118950. [PMID: 34973766 DOI: 10.1016/j.carbpol.2021.118950] [Reference Citation Analysis]
8 Ewies EF, Sabry E, Bekheit MS, Fouad MA, Vullo D, Supuran CT. Click chemistry-based synthesis of new benzenesulfonamide derivatives bearing triazole ring as selective carbonic anhydrase II inhibitors. Drug Dev Res 2022. [PMID: 35706360 DOI: 10.1002/ddr.21957] [Reference Citation Analysis]
9 Li XY, Wang DP, Li S, Xue WH, Qian XH, Liu KL, Li YH, Lin QQ, Dong G, Meng FH, Jian LY. Discovery of N-(1,3,4-thiadiazol-2-yl)benzamide derivatives containing a 6,7-methoxyquinoline structure as novel EGFR/HER-2 dual-target inhibitors against cancer growth and angiogenesis. Bioorg Chem 2021;119:105469. [PMID: 34915285 DOI: 10.1016/j.bioorg.2021.105469] [Reference Citation Analysis]
10 Pla-lópez A, Castillo R, Cejudo-marín R, García-pedrero O, Bakir-laso M, Falomir E, Carda M. Synthesis and Biological Evaluation of Small Molecules as Potential Anticancer Multitarget Agents. IJMS 2022;23:7049. [DOI: 10.3390/ijms23137049] [Reference Citation Analysis]
11 Zhou L, Song Z, Zhang S, Li Y, Xu J, Guo Y. Construction and antitumor activity of selenium nanoparticles decorated with the polysaccharide extracted from Citrus limon (L.) Burm. f. (Rutaceae). Int J Biol Macromol 2021:S0141-8130(21)01584-1. [PMID: 34331980 DOI: 10.1016/j.ijbiomac.2021.07.142] [Reference Citation Analysis]